Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Analytical Biochemistry
|
February 16, 2010
Domain-level stability of an antibody monitored by reduction, differential alkylation, and mass spectrometry analysis
Hongcheng Liu, Chris Chumsae, Georgeen Gaza-Bulseco, et al.
BMC Structural Biology
|
February 2, 2010
Analysis of the role of PCNA-DNA contacts during clamp loading
Randall McNally, Gregory D Bowman, Eric R Goedken, et al.
BMC Structural Biology
|
January 13, 2006
Crystal structure of a DNA polymerase sliding clamp from a Gram-positive bacterium
Maria A Argiriadi, Eric R Goedken, Irina Bruck, et al.
FEBS Letters
|
February 1, 2005
DNA polymerase clamp loaders and DNA recognition
Gregory D Bowman, Eric R Goedken, Steven L Kazmirski, et al.
Journal of Molecular Biology
|
March 24, 2004
Fluorescence measurements on the E.coli DNA polymerase clamp loader: implications for conformational changes during ATP and clamp binding
Eric R Goedken, Marcia Levitus, Aaron Johnson, et al.
Nature Structural & Molecular Biology
|
January 25, 2005
Mapping the interaction of DNA with the Escherichia coli DNA polymerase clamp loader complex
Eric R Goedken, Steven L Kazmirski, Gregory D Bowman, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
July 12, 2018
Merits and Pitfalls in the Characterization of Covalent Inhibitors of Bruton's Tyrosine Kinase
Christopher M Harris, Sage E Foley, Eric R Goedken, et al.
Journal of Biomolecular Screening
|
July 16, 2008
HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity
Eric R Goedken, Andrew I Gagnon, Gary T Overmeyer, et al.
Journal of Biomolecular Screening
|
May 16, 2012
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays
Eric R Goedken, Viswanath Devanarayan, Christopher M Harris, et al.
Modern Rheumatology
|
June 5, 2018
ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation
Christian Goess, Christopher M Harris, Sara Murdock, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Analytical Biochemistry
|
February 16, 2010
Domain-level stability of an antibody monitored by reduction, differential alkylation, and mass spectrometry analysis
Hongcheng Liu, Chris Chumsae, Georgeen Gaza-Bulseco, et al.
BMC Structural Biology
|
February 2, 2010
Analysis of the role of PCNA-DNA contacts during clamp loading
Randall McNally, Gregory D Bowman, Eric R Goedken, et al.
BMC Structural Biology
|
January 13, 2006
Crystal structure of a DNA polymerase sliding clamp from a Gram-positive bacterium
Maria A Argiriadi, Eric R Goedken, Irina Bruck, et al.
FEBS Letters
|
February 1, 2005
DNA polymerase clamp loaders and DNA recognition
Gregory D Bowman, Eric R Goedken, Steven L Kazmirski, et al.
Journal of Molecular Biology
|
March 24, 2004
Fluorescence measurements on the E.coli DNA polymerase clamp loader: implications for conformational changes during ATP and clamp binding
Eric R Goedken, Marcia Levitus, Aaron Johnson, et al.
Nature Structural & Molecular Biology
|
January 25, 2005
Mapping the interaction of DNA with the Escherichia coli DNA polymerase clamp loader complex
Eric R Goedken, Steven L Kazmirski, Gregory D Bowman, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
July 12, 2018
Merits and Pitfalls in the Characterization of Covalent Inhibitors of Bruton's Tyrosine Kinase
Christopher M Harris, Sage E Foley, Eric R Goedken, et al.
Journal of Biomolecular Screening
|
July 16, 2008
HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity
Eric R Goedken, Andrew I Gagnon, Gary T Overmeyer, et al.
Journal of Biomolecular Screening
|
May 16, 2012
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays
Eric R Goedken, Viswanath Devanarayan, Christopher M Harris, et al.
Modern Rheumatology
|
June 5, 2018
ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation
Christian Goess, Christopher M Harris, Sara Murdock, et al.
Page
of 3